What's in A.O.U. Città della Salute e della Scienza's pipeline?

A.O.U. Città della Salute e della Scienza has 5 drugs in our index: 2 marketed, 0 filed, 1 in Phase 3, 2 in Phase 2, 0 in Phase 1.

Which companies overlap with A.O.U. Città della Salute e della Scienza's portfolio?

No competitive overlap detected.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/a-o-u-citt-della-salute-e-della-scienza.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

A.O.U. Città della Salute e della Scienza — Portfolio Competitive Intelligence Brief

A.O.U. Città della Salute e della Scienza pipeline: 2 marketed, 0 filed, 1 Phase 3, 2 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

2 marketed 0 filed 1 Phase 3 2 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Intranasal glugagon	Intranasal glugagon	marketed	Hormonal	Liver	Metabolic
Intravenous Infusion of Diclofenac Sodium	Intravenous Infusion of Diclofenac Sodium	marketed
Bentelan	Bentelan	phase 3			Other

Therapeutic area mix

Metabolic · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

No competitive overlap data.

Subscribe to ongoing alerts

Every new pipeline event for A.O.U. Città della Salute e della Scienza:

Cite this brief

Drug Landscape (2026). A.O.U. Città della Salute e della Scienza — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/a-o-u-citt-della-salute-e-della-scienza. Accessed 2026-05-16.